Horizon Pharma in $75M ATM Transaction

Print More

HZNPOn August 14, 2012, Horizon Pharma, Inc. (HZNP) announced that it has secured up to $75 million in an ATM (At the Market) transaction.

The purchase price is the prevailing market price at the time of the Draw Down Notice. Cowen and Company, LLC acted as the exclusive agent on the transaction. Placement Agent counsel was Goodwin Procter, LLP and issuer counsel was Cooley LLP. An agreement was reached on 08/14/2012.

See PlacementTracker Deal Summary.

Comments are closed.